Marfan syndrome (MFS) is a genetic disorder that affects connective tissue, leading to a range of symptoms that can impact various systems in the body, particularly the cardiovascular system.
The standard treatment for the connective tissue disorder Marfan's syndrome (MFS) is β-blockade, aimed at reducing aortic wall stress. Angiotensin II type 1 and 2 receptors (AT 1 and AT 2 ...